Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 584

1.

The current status of thermal ablation in the management of T1b renal masses.

Welch BT, Shah PH, Thompson RH, Atwell TD.

Int J Hyperthermia. 2019 Oct;36(2):31-36. doi: 10.1080/02656736.2019.1605097.

PMID:
31537163
2.

Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.

Murray CA, Welch BT, Schmit GD, Schmitz JJ, Weisbrod AJ, Callstrom MR, Welch TL, Thompson RH, Kurup AN, Boorjian SA, Atwell TD.

Urology. 2019 Aug 12. pii: S0090-4295(19)30713-7. doi: 10.1016/j.urology.2019.08.005. [Epub ahead of print]

PMID:
31415781
3.

Complete Surgical Metastasectomy for Renal Cell Carcinoma in the Post-cytokine Era.

Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC.

J Urol. 2019 Aug 8:101097JU0000000000000488. doi: 10.1097/JU.0000000000000488. [Epub ahead of print]

PMID:
31393812
4.

Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms.

Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH.

Urology. 2019 Jul 26. pii: S0090-4295(19)30652-1. doi: 10.1016/j.urology.2019.07.017. [Epub ahead of print]

PMID:
31356826
5.

Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC.

Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE.

Hum Pathol. 2019 Sep;91:114-122. doi: 10.1016/j.humpath.2019.07.004. Epub 2019 Jul 9.

PMID:
31299266
6.

Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney.

Denic A, Ricaurte L, Lopez CL, Narasimhan R, Lerman LO, Lieske JC, Thompson RH, Kremers WK, Rule AD.

J Am Soc Nephrol. 2019 Aug;30(8):1471-1480. doi: 10.1681/ASN.2019020183. Epub 2019 Jul 5.

PMID:
31278193
7.

Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ.

Eur Urol Oncol. 2019 Jul;2(4):390-396. doi: 10.1016/j.euo.2018.09.004. Epub 2018 Sep 28.

PMID:
31277775
8.

Evaluation of Medical School Grading Variability in the United States: Are All Honors the Same?

Westerman ME, Boe C, Bole R, Turner NS, Rose SH, Gettman MT, Thompson RH.

Acad Med. 2019 Jun 18. doi: 10.1097/ACM.0000000000002843. [Epub ahead of print]

PMID:
31219812
9.

Cytoreductive Nephrectomy in the Wake of CARMENA: When to Consider it.

Sharma V, Thompson RH.

Eur Urol Oncol. 2019 Jul;2(4):379-380. doi: 10.1016/j.euo.2019.05.003. Epub 2019 Jun 13. No abstract available.

PMID:
31202713
10.

Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?

Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 Sep;76(3):e67-e68. doi: 10.1016/j.eururo.2019.05.033. Epub 2019 Jun 2. No abstract available.

PMID:
31167750
11.

The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.

Salagierski M, Wojciechowska A, Zając K, Klatte T, Thompson RH, Cadeddu JA, Kaouk J, Autorino R, Ahrar K, Capitanio U; Young Academic Urologists Kidney Cancer Working Group of the European Urological Association.

Eur Urol Oncol. 2018 Oct;1(5):395-402. doi: 10.1016/j.euo.2018.08.029. Epub 2018 Sep 24. Review.

PMID:
31158078
12.

Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy of Localized Prostate Cancer: An Analysis of the ProtecT Trial.

Sharma V, Wymer KM, Borah BJ, Barocas DA, Thompson RH, Karnes RJ, Boorjian SA.

J Urol. 2019 May 21:101097JU0000000000000345. doi: 10.1097/JU.0000000000000345. [Epub ahead of print]

PMID:
31112105
13.

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.

Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3.

PMID:
31060824
14.

JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.

Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE.

Mod Pathol. 2019 Sep;32(9):1344-1358. doi: 10.1038/s41379-019-0269-x. Epub 2019 Apr 17.

PMID:
30996253
15.

Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection.

Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA.

J Urol. 2019 Jul;202(1):69-75. doi: 10.1097/JU.0000000000000171. Epub 2019 Jun 7.

PMID:
30925222
16.

Tumor Enucleation is Appropriate During Partial Nephrectomy: Against.

Tsivian M, Packiam VT, Thompson RH.

Eur Urol Focus. 2019 Mar 22. pii: S2405-4569(19)30085-9. doi: 10.1016/j.euf.2019.03.010. [Epub ahead of print]

PMID:
30910392
17.

Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ.

World J Urol. 2019 Feb 25. doi: 10.1007/s00345-019-02689-8. [Epub ahead of print]

PMID:
30805684
18.

Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.

Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, Machha V, Gordon-Mitchell S, Choudhary G, Wong LF, Gross L, Ressigue E, Leibovich B, Boorjian SA, Steidl U, Wu X, Pradhan K, Gartrell B, Agarwal B, Pagliaro L, Suzuki M, Greally JM, Rakheja D, Thompson RH, Susztak K, Witzig T, Zou Y, Verma A.

J Clin Invest. 2019 Mar 4;130:1612-1625. doi: 10.1172/JCI98747. eCollection 2019 Mar 4.

19.

Comprehensive characterization of perioperative reoperation following radical cystectomy.

Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK.

Urol Oncol. 2019 Apr;37(4):292.e11-292.e17. doi: 10.1016/j.urolonc.2018.11.023. Epub 2019 Jan 22.

PMID:
30679081
20.

Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy.

Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ.

Int Braz J Urol. 2019 May-Jun;45(3):468-477. doi: 10.1590/S1677-5538.IBJU.2018.0196.

21.

Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer.

Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA.

Urology. 2019 Apr;126:134-139. doi: 10.1016/j.urology.2018.12.037. Epub 2019 Jan 12.

PMID:
30648561
22.

Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience.

Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ.

BJU Int. 2019 Jun;123(6):1011-1019. doi: 10.1111/bju.14612. Epub 2019 Jan 8.

PMID:
30623554
23.

Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience.

Atwell TD, Schultz GG, Leibovich BC, Schmit GD, Boorjian SA, Kurup AN, Thompson RH, Yost KJ.

AJR Am J Roentgenol. 2019 Mar;212(3):672-676. doi: 10.2214/AJR.17.19463. Epub 2019 Jan 8.

PMID:
30620680
24.

Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer.

Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ.

Scand J Urol. 2018 Oct - Dec;52(5-6):340-348. doi: 10.1080/21681805.2018.1534886. Epub 2019 Jan 2.

PMID:
30600747
25.

How Teaching Perspective Taking to Individuals with Autism Spectrum Disorders Affects Social Skills: Findings from Research and Suggestions for Practitioners.

Peters LC, Thompson RH.

Behav Anal Pract. 2018 Jan 29;11(4):467-478. doi: 10.1007/s40617-018-0207-2. eCollection 2018 Dec 31.

26.

Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.

Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2019 May;75(5):766-772. doi: 10.1016/j.eururo.2018.11.021. Epub 2018 Nov 23.

PMID:
30477983
27.

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.

Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Rouprêt M, Abufaraj M, Foerster B, Gönen M, Shariat SF.

World J Urol. 2019 Aug;37(8):1631-1637. doi: 10.1007/s00345-018-2555-5. Epub 2018 Nov 7.

28.

A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease.

Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA.

World J Urol. 2019 Aug;37(8):1605-1613. doi: 10.1007/s00345-018-2551-9. Epub 2018 Nov 3.

PMID:
30392012
29.

Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.

Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Eur Urol. 2018 Dec;74(6):825-832. doi: 10.1016/j.eururo.2018.08.028. Epub 2018 Sep 24.

PMID:
30262341
30.

The rooting reflex as an infant feeding cue.

Glodowski KR, Thompson RH, Martel L.

J Appl Behav Anal. 2019 Feb;52(1):17-27. doi: 10.1002/jaba.512. Epub 2018 Sep 24.

PMID:
30251406
31.

Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned.

Thompson SM, Schmitz JJ, Thompson RH, Weisbrod AJ, Welch BT, Viers BR, Hannon JD, Schmit GD, Atwell TD, Kurup AN.

AJR Am J Roentgenol. 2018 Dec;211(6):1381-1389. doi: 10.2214/AJR.18.19775. Epub 2018 Sep 24.

PMID:
30247980
32.

Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era.

Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Urol Oncol. 2018 Nov;36(11):499.e1-499.e7. doi: 10.1016/j.urolonc.2018.08.008. Epub 2018 Sep 15.

PMID:
30228096
33.

Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.

Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH.

BJU Int. 2019 Feb;123(2):270-276. doi: 10.1111/bju.14523. Epub 2018 Sep 9.

PMID:
30113768
34.

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Shenoy N, Mudireddy M, Vallapureddy R, Leung N, Pagliaro L, Witzig T, Ou FS, Ordog T, Cheville J, Patnaik M, Thompson RH, Tefferi A, Begna K.

Clin Genitourin Cancer. 2018 Dec;16(6):e1117-e1122. doi: 10.1016/j.clgc.2018.06.008. Epub 2018 Jun 28.

PMID:
30077464
35.

Predictors of Scholarly Productivity, Pursuit of Fellowship, and Academic Practice Among Urology Residents Using Medical Student Application Materials.

Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT.

Urology. 2018 Oct;120:49-55. doi: 10.1016/j.urology.2018.07.016. Epub 2018 Jul 19.

PMID:
30031833
36.

The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.

Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC.

Eur Urol. 2018 Oct;74(4):489-497. doi: 10.1016/j.eururo.2018.06.003. Epub 2018 Jul 13.

PMID:
30017400
37.

Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.

Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD.

J Vasc Interv Radiol. 2018 Aug;29(8):1122-1126. doi: 10.1016/j.jvir.2018.02.029. Epub 2018 Jun 7.

PMID:
29887184
38.

Temporal trends in venous thromboembolism after radical cystectomy.

Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA.

Urol Oncol. 2018 Aug;36(8):361.e15-361.e21. doi: 10.1016/j.urolonc.2018.05.015. Epub 2018 Jun 7.

PMID:
29885792
39.

The Association of Aspirin Use with Survival Following Radical Cystectomy.

Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA.

J Urol. 2018 Nov;200(5):1014-1021. doi: 10.1016/j.juro.2018.05.119. Epub 2018 May 30.

PMID:
29857079
40.

The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.

Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA.

J Urol. 2018 Nov;200(5):981-988. doi: 10.1016/j.juro.2018.05.081. Epub 2018 May 22.

PMID:
29792881
41.

Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.

Denic A, Mathew J, Nagineni VV, Thompson RH, Leibovich BC, Lerman LO, Lieske JC, Alexander MP, Augustine JJ, Kremers WK, Rule AD.

J Am Soc Nephrol. 2018 Jul;29(7):1960-1969. doi: 10.1681/ASN.2017121305. Epub 2018 May 22. Erratum in: J Am Soc Nephrol. 2018 Sep;29(9):2445.

42.

Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR.

J Urol. 2018 Sep;200(3):520-527. doi: 10.1016/j.juro.2018.04.069. Epub 2018 Apr 27.

PMID:
29709665
43.

Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes.

Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, Leibovich BC, Boorjian SA, Thompson RH.

BJU Int. 2018 Aug;122(2):243-248. doi: 10.1111/bju.14221. Epub 2018 Apr 29.

44.

Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma.

Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH, Leibovich BC, Boorjian SA.

J Urol. 2018 Sep;200(3):528-534. doi: 10.1016/j.juro.2018.03.077. Epub 2018 Mar 21.

PMID:
29574109
45.

Reply by the Authors.

Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT.

Urology. 2018 May;115:190. doi: 10.1016/j.urology.2018.02.001. Epub 2018 Mar 12. No abstract available.

PMID:
29545040
46.

Imaging following renal ablation: what can we learn from recurrent tumors?

Eiken PW, Atwell TD, Kurup AN, Boorjian SA, Thompson RH, Schmit GD.

Abdom Radiol (NY). 2018 Oct;43(10):2750-2755. doi: 10.1007/s00261-018-1541-0.

PMID:
29525875
47.

A Comparison of Bleeding Complications in Patients Undergoing Percutaneous Renal Cryoablation Using Cryoprobes with and without Heat-Based Track Ablation.

Schmit CH, Callstrom MR, Boorjian SA, Johnson MP, Atwell TD, Kurup AN, Schultz GR, Thompson RH, Schmit GD.

J Vasc Interv Radiol. 2018 Jun;29(6):874-879. doi: 10.1016/j.jvir.2017.11.009. Epub 2018 Mar 3.

PMID:
29506903
48.

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.

Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V.

Urology. 2018 May;115:119-124. doi: 10.1016/j.urology.2018.02.019. Epub 2018 Feb 27.

PMID:
29499258
49.

Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.

Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP.

Eur Urol. 2018 May;73(5):772-780. doi: 10.1016/j.eururo.2018.01.005. Epub 2018 Feb 3.

PMID:
29398265
50.

The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review.

Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H.

Minerva Urol Nefrol. 2018 Apr;70(2):109-125. doi: 10.23736/S0393-2249.18.03055-2. Epub 2018 Jan 29.

Supplemental Content

Loading ...
Support Center